Fulcrum Pharma plc is an independent public company incorporated in the United Kingdom. The company offers a unique global strategic drug development and regulatory service to the pharmaceutical and biotechnology industries through offices in Europe, the USA and Japan. These services include the planning, design, execution and delivery of drug development programmes resulting in customised development solutions for client companies.

In compliance with Rule 26 of the AIM rules for Companies, the following information has been provided for the benefit of investors. Please browse the links below for more information.

Interested in learning more about Fulcrum?

Contact us via .